Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

3325 with DOI

7 strong · 24 moderate · 2 weak

Compilations

12026-05-07T20:58:29.723Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

45last ruled 2026-10-02

0 awaiting a ruling

Issued documents

62026-10-19T20:31:20.042Z

notice · info card · emergency

Searches

160 with no results

queries and counts on the build

Claims checked

8144 supported

44 supported · 37 not

Correspondence

0received

consent field ships in Phase 4

Edges

277

derivations recorded for this entity

Complete over 33 sources, 1 compilation, and 45 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/delta-8-thc/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-02issueIssued info_card
  4. 2026-10-02srcU.S. State Marijuana and Delta-8-Tetrahydrocannabinol Laws and Delta-8-Tetrahydrocannabinol Use
  5. 2026-10-02srcAssessment of dependence potential and abuse liability of Δ8-tetrahydrocannabinol in mice
  6. 2026-10-02srcA within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults
  7. 2026-10-02srcA within-subject cross-over trial comparing the acute effects of vaporized delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults
  8. 2026-10-02srcPatterns of delta 8 THC and cannabis uptake in Nebraska: A cannabis prohibition state
  9. 2026-10-02srcEvaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
  10. 2026-10-02srcEasy and Accessible Synthesis of Cannabinoids from CBD
  11. 2026-10-02srcDelta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America's Poison Centers
  12. 2026-10-02srcΔ8-THC: Legal Status, Widespread Availability, and Safety Concerns
  13. 2026-10-02srcPharmacokinetics of Oral Minor Cannabinoids in Blood and Brain
  14. 2026-10-02srcLC-MS-MS quantification of Δ8-THC, Δ9-THC, THCV isomers and their main metabolites in human plasma
  15. 2026-10-02srcPharmacokinetic study of delta-8-tetrahydrocannabinol in male rats using a validated bioanalytical method
  16. 2026-10-02srcReview of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC
  17. 2026-10-02srcInvestigation of the toxic dose of ingested delta-8 tetrahydrocannabinol among young children
  18. 2026-10-02srcMinnesota wild hemp: a crucial botanical source in early cannabinoid discovery
  19. 2026-10-02srcDelta-8-THC: Delta-9-THC's nicer younger sibling?
  20. 2026-10-02srcEnhanced solubility, stability, and transcorneal permeability of delta-8-tetrahydrocannabinol in the presence of cyclodextrins
  21. 2026-10-02srcPharmacokinetics of Two Nanoemulsion Formulations of Δ8-Tetrahydrocannabinol in Rats
  22. 2026-10-02srcCharacterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
  23. 2026-10-02srcDelta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
  24. 2026-10-02srcSystematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis
  25. 2026-10-02srcAre Cannabis-Based Medicines a Useful Treatment for Neuropathic Pain? A Systematic Review
  26. 2026-10-02srcAllosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
  27. 2026-10-02srcDelta-8 Tetrahydrocannabinol Product Impurities
  28. 2026-10-02srcChemistry and Pharmacology of Delta-8-Tetrahydrocannabinol
  29. 2026-10-02srcSeparation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues
  30. 2026-10-02srcBehavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats
  31. 2026-10-02srcAnalgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial
  32. 2026-10-02srcCannabinoids in glaucoma: a primary screening procedure.
  33. 2026-10-02srcCannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit
  34. 2026-10-02srcAn efficient new cannabinoid antiemetic in pediatric oncology
  35. 2026-10-02srcCDC Health Advisory: Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events (HAN 00451)
  36. 2026-10-02src5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC
  37. 2026-10-02publicationPublication — publishagent-psx
  38. 2026-10-02revisionr1.a1
  39. 2026-10-02rulingRuling — psx:substance/delta-8-thc/proposal/article_section_proposals/5605fa19-189a-455e-b2a7-61681c2af765founder
  40. 2026-10-02rulingRuling — psx:substance/delta-8-thc/proposal/article_section_proposals/9b1a6c27-e712-41a9-bc03-7c4fd8bd1062founder
  41. 2026-09-04issueIssued emergency
  42. 2026-09-04issueIssued info_card
  43. 2026-09-04issueIssued notice
  44. 2026-06-04proposal39 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  45. 2026-06-04publicationPublication — backfill
  46. 2026-05-07revisionRevision 1
  47. 2026-05-07genGeneration — pipeline-v5 · with 1 morepipeline-v5
  48. 2026-05-07rungeneration run

The same entries, as forms: six forms.